These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 12121558)
21. High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease. Muro Y; Sugiura K; Morita Y; Tomita Y Lupus; 2008 Mar; 17(3):171-6. PubMed ID: 18372356 [TBL] [Abstract][Full Text] [Related]
22. Autoantibodies to Dense Fine Speckles in Pediatric Diseases and Controls. Schmeling H; Mahler M; Levy DM; Moore K; Stevens AM; Wick J; McMillan JD; Horneff G; Assassi S; Charles J; Salazar G; Mayes MD; Silverman ED; Klien-Gitelman M; Lee T; Brunner HI; Reed AM; Fritzler MJ J Rheumatol; 2015 Dec; 42(12):2419-26. PubMed ID: 26472409 [TBL] [Abstract][Full Text] [Related]
23. Dense fine speckled indirect immunofluorescence pattern in an Australian population. Broadfoot A; Sivertsen T; Baumgart K Pathology; 2016 Apr; 48(3):247-50. PubMed ID: 27020500 [TBL] [Abstract][Full Text] [Related]
24. Autoantibodies and rheumatic disorders in a neurology inpatient population: a prospective study. Olsen ML; O'Connor S; Arnett FC; Rosenbaum D; Grotta JC; Warner NB Am J Med; 1991 Apr; 90(4):479-88. PubMed ID: 1901447 [TBL] [Abstract][Full Text] [Related]
25. Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases. Mariz HA; Sato EI; Barbosa SH; Rodrigues SH; Dellavance A; Andrade LE Arthritis Rheum; 2011 Jan; 63(1):191-200. PubMed ID: 20954189 [TBL] [Abstract][Full Text] [Related]
26. Association between demyelinating disease and autoimmune rheumatic disease in a pediatric population. Amorim ALM; Cabral NC; Osaku FM; Len CA; Oliveira EML; Terreri MT Rev Bras Reumatol Engl Ed; 2017; 57(3):224-228. PubMed ID: 28535894 [TBL] [Abstract][Full Text] [Related]
27. [Rheumatic manifestations in HIV infection]. Seglias J; Aeschlimann A; Müller W Z Rheumatol; 1990; 49(6):324-8. PubMed ID: 2085054 [TBL] [Abstract][Full Text] [Related]
28. Musculoskeletal manifestations of infection with human immunodeficiency virus. Buskila D; Gladman D Rev Infect Dis; 1990; 12(2):223-35. PubMed ID: 2184493 [TBL] [Abstract][Full Text] [Related]
29. The association of solid-phase assays to immunofluorescence increases the diagnostic accuracy for ANA screening in patients with autoimmune rheumatic diseases. Bizzaro N; Brusca I; Previtali G; Alessio MG; Daves M; Platzgummer S; Cinquanta L; Paura G; Infantino M; Manfredi M; Faricelli R; Bassetti D; Musso M; Deleonardi G; Trevisan MT; Radice A; Liguori M; Imbastaro T; Pesente F; Fabris M; Tonutti E Autoimmun Rev; 2018 Jun; 17(6):541-547. PubMed ID: 29631063 [No Abstract] [Full Text] [Related]
30. Diagnostic and prognostic significance of different antinuclear antibodies in more than 1000 consecutive Albanian patients with rheumatic diseases. Sulcebe G; Morcka K Clin Exp Rheumatol; 1992; 10(3):255-61. PubMed ID: 1582070 [TBL] [Abstract][Full Text] [Related]
31. Fatigue severity in anti-nuclear antibody-positive individuals does not correlate with pro-inflammatory cytokine levels or predict imminent progression to symptomatic disease. Hafiz W; Nori R; Bregasi A; Noamani B; Bonilla D; Lisnevskaia L; Silverman E; Bookman AAM; Johnson SR; Landolt-Marticorena C; Wither J Arthritis Res Ther; 2019 Nov; 21(1):223. PubMed ID: 31685018 [TBL] [Abstract][Full Text] [Related]
32. Clinical significance of antinuclear antibodies in malignant diseases: association with rheumatic and connective tissue paraneoplastic syndromes. Solans-Laqué R; Pérez-Bocanegra C; Salud-Salvia A; Fonollosa-Plá V; Rodrigo MJ; Armadans L; Simeón-Aznar CP; Vilardell-Tarres M Lupus; 2004; 13(3):159-64. PubMed ID: 15119543 [TBL] [Abstract][Full Text] [Related]
33. [Prevalence of rheumatic manifestations in human immunodeficiency virus infection]. Rogeaux O; Fassin D; Gentilini M Ann Med Interne (Paris); 1993; 144(7):443-8. PubMed ID: 8141504 [TBL] [Abstract][Full Text] [Related]
34. [Rheumatic disease as initial symptom of HIV infection]. Arend SM; Westedt ML; Hogewind BL Ned Tijdschr Geneeskd; 1992 Mar; 136(12):584-6. PubMed ID: 1552970 [TBL] [Abstract][Full Text] [Related]
35. [Rheumatological manifestations in HIV infections]. Melaku Z; Haga HJ Tidsskr Nor Laegeforen; 2000 Apr; 120(11):1326-8. PubMed ID: 10868096 [TBL] [Abstract][Full Text] [Related]
36. Prevalence of rheumatic disease in HIV infected Thai patients. Chiowchanwisawakit P; Koolvisoot A; Ratanasuwan W; Suwanagool S J Med Assoc Thai; 2005 Dec; 88(12):1775-81. PubMed ID: 16518973 [TBL] [Abstract][Full Text] [Related]
37. Autoimmune diseases-related arthritis in HIV-infected patients in the era of highly active antiretroviral therapy. Yang JJ; Tsai MS; Sun HY; Hsieh SM; Chen MY; Sheng WH; Chang SC J Microbiol Immunol Infect; 2015 Apr; 48(2):130-6. PubMed ID: 24064287 [TBL] [Abstract][Full Text] [Related]
38. Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases. Mahler M; Parker T; Peebles CL; Andrade LE; Swart A; Carbone Y; Ferguson DJ; Villalta D; Bizzaro N; Hanly JG; Fritzler MJ J Rheumatol; 2012 Nov; 39(11):2104-10. PubMed ID: 22942262 [TBL] [Abstract][Full Text] [Related]
39. [Antinuclear antibodies without connective tissue disease : Antibodies against LEDGF/DSF70]. Mierau R Z Rheumatol; 2016 May; 75(4):372-80. PubMed ID: 26820723 [TBL] [Abstract][Full Text] [Related]
40. Are we at a stage to predict autoimmune rheumatic diseases? Bizzaro N; Tozzoli R; Shoenfeld Y Arthritis Rheum; 2007 Jun; 56(6):1736-44. PubMed ID: 17530702 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]